Trademark

NordicEndotrophin Trademark Information

Number:
2487447
Ir number:
1812649
Words:
nordicEndotrophin
Kind:
Word
Status group:
NEVER_REGISTERED
Status code:
Not protected
Status detail:
Not accepted
Priority date:
21 Mar 2024
Lodgement date:
23 Aug 2024
Ir notification date:
03 Oct 2024
Ir renewal due date:
23 Aug 2034
First report date:
09 Oct 2024
Acceptance due date:
09 Jan 2026
Renewal due date:
23 Aug 2034
Lapsed date:
09 Jan 2026
Filing date:
23 Aug 2024
Ir contact:
, , CHAS. HUDE A/S, , Array
Indexing constituents:
NORDICENDOTROPHIN, NORDIC, ENDOTROPHIN
Class:
5,42
Endorsements:
The applicant has advised that the words in the Mark have no meaning in English
Convention details:
Array
Mark categories:
Trademark
Last status check:
2026-07-01 18:45:19
Goods and services:
1) Class: 5
Description: Diagnostic biomarker reagents for medical and clinical purposes, biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction, biomarker assays to identify disease activity, biomarker assays to quantify disease activity, biomarker assays to analyse disease activity, diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity, medical diagnostic agents, medical diagnostic reagents, clinical diagnostic agents, clinical diagnostic reagents, diagnostic preparations, substances and materials, medical diagnostic test strips, diagnostic preparations for medical purposes, diagnostic agents for medical use.
2) Class: 42
Description: Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity, design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes, design and development of biochemical, pharmaceutical, and medical assays, design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction, scientific and pharmaceutical research in the field of biomarkers and biomarker discovery, identification of predictive and prognostic biomarkers for clinical trials, identifing patients for clinical trials most likely to respond to a given treatment using biomarkers, laboratory services relating to clinical trials, clinical trials, analysis of pharmacodynamic data, analysis of data relating to biomarkers, development of diagnostic preparations, equipment and tests, clinical testing services, diagnostic testing services, testing services relating to the detection and measurement of biomarkers, testing samples for the presence of biomarkers, laboratory services, medical laboratory services, research laboratory services, medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis, advice, information and assistance relating to the foregoing.
History and publication details:
1) Date: 2026-01-21
Display name: International Registration in Australia Refused correspondence sent
2) Date: 2026-01-20
Display name: Status change to Lapsed/Not Protected
3) Date: 2025-10-04
Display name: IRDA - Opposition Still Possible Notice correspondence sent
4) Date: 2024-10-10
Display name: Adverse Report (Examination) correspondence sent
5) Date: 2024-10-09
Display name: IP Right has been Examined
6) Date: 2024-10-03
Display name: Examination expedited
7) Date: 2024-10-03
Display name: Awaiting examination
8) Date: 2024-10-03
Display name: Word and image indexing completed
9) Date: 2024-10-03
Display name: IP Right Filed Published
10) Date: 2024-10-03
Display name: Status change to Published
11) Date: 2024-10-03
Display name: Status change to Filed
12) Date: 2024-10-03
Display name: IP right goods and service classes updated
Description: Class Count: 2 Class Numbers:5; 42
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 2 Class Numbers: 5; 42
13) Date: 2024-10-03
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.
14) Date: 2024-10-03
Display name: IP Right Goods and Services Items updated
Description: Class Number: 42
Previous details:
New details: Class Number: 42 Class Items: Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.
15) Date: 2024-10-03
Display name: Status change to Received
16) Date: 2024-10-03
Display name: Trade mark representation updated
17) Date: 2024-10-03
Display name: Application Received

Owner Information
Owner structured address:
Herlev Hovedgade 205 DK-2730 Herlev, DENMARK

Owner is private:
0
Scroll to Top